Haemaglobinopathies Flashcards
What is a haemoglobinopathy
The normal production of structurally abnormal globin chains
What may cause haemoglobinopathies
(4)
Point mutations
Deletion of triplets
Mutation of a stop codon
A fusion mutation or due to an insertion
Give some examples of haemoglobin varients
Hb C
Hb S/C
Hb E
Hb D
What is Hb C
B6 Glu>lys
Results in mild haemolytic anaemia
What is Hb S/C
This accounts for 20-50% of patients with sickle cell disease
Causes less severe vaso-occlucive complications
What is Hb E
(3)
Most common mutation
B26 Glu.lys
Homozygotes suffer from mild anaemia
What is Hb D
(2)
B121 Glu>Gln
Mostly asymptomatic
What percentage of west Africans have sickle cell disease
1 in 4
Comment on the severity of sickle cell disease
(6)
HbS
Heterozygotes are asymptomatic
Homozygotes have SCD
Haemolytic anaemia of varying severity punctuated by painful sickling crises
Reduced life expectancy with most people suffering in Nigeria dying before 21 years of age
Approximately 20% of children die under 5 in Africa
How does sickle cell disease confer protection against malaria
(3)
Hb S shape is difficult for the malaria parasite to use
Macrophages will also continuously break down these sickle cells
Parasites are unable to get to the end of their life cycle before being phagocytosed along with the sickle cell
What causes structural/qualitative defects of Hb
Occurs when the amino acid sequence of one globin chain is altered
Mutation may arise due to addition, substitution, deletion or fusion to the base sequence in the globin chain -> this leads to a change in the amino acid sequence
Leads to sickle cell anaemia
How does sickle cell anaemia come about
(5)
Due to a change in the base sequence of the B chain
An A is changed to a T
GAG»_space;> GTG
This results in the replacement of glutamic acid by valine at position 6 on the B chain
This causes a change in the overall charge and polarity of the molecule
How is HbS diagnosed in the lab
(7)
Positive solubility test
Blood film
Full Blood Count
DNA analysis to confirm genetic mutation
Electrophoresis
HPLC
General bloods
How is a blood film used to diagnosed HbS
(7)
Sickle cells
Target cells
Polychromasia
Hypochromic microcytes
Reticulocytes
NRBC
Howel Jolly bodies if hyposplenic
How is a full blood count used to diagnose HbS
Haemoglobin is low
MCV is low
MCH is low
How is High Performance Liquid Chromatography used to diagnose Hb
(4)
Hb A is absent
Hb S 80-100%
Hb F 5-15%
Increased HbA2
How is the Bio-Rad Varient II used in the primary screening of B-thalassaemia
(6)
Analyser utilises ion-exchange HPLC to investigate B-thalassaemia
A B-thalassaemia short program test kit is used with the analyser
Samples are diluted and mixed at the sampling station and then injected into the analytical cartridge
Hb is fractioned by type, based on its ionic interactions with the reagent
Results are shown as a chromatogram
The analyser is usually interfaced to the Laboratory Information System (LIS)
How is the Sebia Capillarys 2 Flex Piercing - Confirmatory Testing used
(3)
Analyser uses capillary electrophoresis to confirm thalassaemia and other haemoglobinopathies
Works by separating charged molecules by their electrophoretic mobility in an alkaline buffer when voltage is applied
The Hb fractions are detected at 415nm at the cathode of the capillary and an electrophoretogram is produced, together with quantified fractions of Hb
How is sickle cell anaemia treated
(4)
Drug treatments
Allogenic transplant
Ex vivo gene therapy
In vivo gene therapy
How are drugs used to treat sickle cell anaemia
These aim to allow more cells to transit the microcirculation before sickling
How are allogeneic transplants used to treat sickle cell anaemia
Bone marrow stem cells from a donor without SCD are transplanted
How will Ex vivo gene therapy be used in the future to treat SCD
The patients bone marrow cells are modified by adding a B-globin gene using a retroviral vector or with gene editing
This will reactivate foetal haemoglobin (HbF) or correct the disease mutation
How will Ex vivo gene therapy be used in the future to treat SCD
The patients bone marrow cells will be modified by adding a B-globin gene
This will be done using either a retroviral vector or with gene editing
This will reactivate foetal haemoglobin or correct the disease mutation
How will In vivo gene therapy be used in the future to treat SCD
Direct gene editing in patients could circumvent the need for transplantation of modified patient cells if sufficient efficiency and safety can be achieved
What are quantitative abnormalities of Hb
Heterogenous group of genetic disorders which result from a reduced rate of synthesis of the alpha or Beta globin chains
What causes quantitative abnormalities
May arise because of:
Inadequate amount of mRNA
Unstable mRNA
mRNA that contains untranslatable nonsense message
What happens when there is quantitative abnormalities of Hb (Thalassaemias)?
There is a decrease in one of the globin chains
So the other chain is in excess and thus the molecule is unbalanced and the chain in excess tries to form tetramers and precipitates within the cell